Trazodone is an antidepressant prescribed primarily for major depressive disorder, but in practice, it’s used far more often as a sleep aid. Its strong sedating effect at lower doses has made it one of the most commonly prescribed medications for insomnia in the United States, even though that use was never formally approved by the FDA. If you’ve been prescribed trazodone or are curious about why it’s so widely used, here’s what it actually does and what to expect.
Its Official Use: Treating Depression
Trazodone is FDA-approved for the treatment of major depressive disorder. It works by increasing serotonin activity in the brain, but it does this differently than the more familiar SSRIs like fluoxetine (Prozac) or sertraline (Zoloft). Trazodone is weaker at blocking serotonin reuptake than those medications. Instead, it also blocks certain serotonin receptors that are linked to anxiety and sleep disruption, while activating others that promote a calming effect. This dual action is why it’s sometimes classified as a SARI (serotonin antagonist and reuptake inhibitor).
For depression, the typical starting dose is 150 mg per day, taken in divided doses, with gradual increases every three to four days. The maximum dose reaches 400 mg daily for outpatients and 600 mg for hospitalized patients. At these higher doses, the antidepressant effects become more prominent. It generally takes one to two weeks before you notice any improvement, and four to six weeks to feel the full benefit.
Its Most Common Use: Sleep
The reason most people encounter trazodone has nothing to do with depression. At low doses (typically 25 to 100 mg), its sedating properties kick in strongly, making it a popular choice for insomnia. Drowsiness is the single most reported effect in clinical trials, affecting roughly 24% of hospitalized patients and 41% of outpatients. That side effect, essentially, became the main attraction.
For sleep, trazodone works quickly. Unlike its antidepressant effects, which take weeks to build, the sedation is noticeable the first night. A head-to-head study comparing trazodone 50 mg to zolpidem (Ambien) 10 mg found that both shortened the time it took to fall asleep and increased total sleep duration during the first week. Zolpidem was somewhat more effective at reducing the time to fall asleep, and by the second week, only zolpidem maintained that edge over placebo. Still, trazodone remains popular for sleep because it’s not a controlled substance, carries a lower risk of dependence than traditional sleep medications, and is inexpensive as a generic.
Doctors often prescribe it as a single dose at bedtime. For doses of 300 mg or less, taking it all at once in the evening is standard practice, which conveniently aligns the peak sedation with when you want to be asleep.
Other Off-Label Uses
Trazodone’s combination of sedating and serotonin-modulating effects has led to its use across a range of conditions beyond depression and insomnia. These include anxiety disorders, post-traumatic stress disorder, fibromyalgia, eating disorders, and substance abuse treatment. None of these uses carry FDA approval, but they’re common enough in clinical practice that you may be prescribed trazodone for one of them.
One area where trazodone has shown particular promise is managing behavioral symptoms in dementia. In patients with Alzheimer’s disease and frontotemporal dementia, it has been used to reduce agitation, irritability, anxiety, and restlessness. A small pilot trial in Alzheimer’s patients found that trazodone taken three times daily for 10 weeks improved irritability and anxiety, though it didn’t affect cognitive function itself. Multiple studies have reported benefits for behavioral disturbances in dementia, making it a practical option when agitation or sleep disruption is a major concern for those patients.
Common Side Effects
The sedation that makes trazodone useful for sleep is also its most frequent side effect. In clinical trials, the four most common reactions (occurring in at least 5% of patients and at double the rate of placebo) were drowsiness, dizziness, constipation, and blurred vision.
Looking at the numbers more closely from outpatient trials, the picture becomes clearer:
- Drowsiness: 41% of patients (vs. 20% on placebo)
- Dry mouth: 34% (vs. 20% on placebo)
- Dizziness: 28% (vs. 15% on placebo)
- Blurred vision: 15% (vs. 4% on placebo)
- Nausea or vomiting: 13% (vs. 10% on placebo)
- Fatigue: 6% (vs. 3% on placebo)
Weight changes go in both directions. About 5% of outpatients reported weight gain and a similar percentage reported weight loss, so trazodone doesn’t reliably push weight one way or the other. Headaches affected about 20% of outpatients, though the placebo rate was nearly as high at 16%, suggesting some of that is unrelated to the medication itself.
The side effects that most often led people to stop taking trazodone were drowsiness (4% discontinued) and dizziness (3.5% discontinued). Confusion, coordination problems, headache, nausea, and balance issues each caused about 1% of people to quit the medication.
Serious but Rare Risks
Trazodone can cause low blood pressure, particularly when standing up quickly. In inpatient trials, 7% of patients experienced drops in blood pressure compared to just 1% on placebo. This is especially relevant for older adults, who are more vulnerable to falls from dizziness or lightheadedness.
Priapism, a prolonged and painful erection unrelated to sexual arousal, is a rare but serious risk associated with trazodone. It’s uncommon, but it requires immediate medical attention because it can cause permanent damage if untreated.
Like all medications that increase serotonin activity, trazodone carries a risk of serotonin syndrome when combined with other serotonin-boosting drugs. This is a potentially dangerous condition involving agitation, rapid heart rate, high body temperature, and muscle rigidity. The risk is highest when trazodone is taken alongside MAOIs (a class of older antidepressants), and combining the two is generally avoided entirely. Other serotonin-active medications, including SSRIs and certain migraine drugs, also increase the risk.
How It Compares to Other Antidepressants
Trazodone occupies an unusual position among antidepressants. It’s less potent at blocking serotonin reuptake than SSRIs like fluoxetine or citalopram, which means its antidepressant effect relies on a broader mix of receptor actions. This makes it a less common first choice for depression alone, but a useful option when depression comes with significant insomnia or anxiety, since its sedating and calming effects address both problems simultaneously.
One practical advantage over SSRIs is that trazodone is less likely to cause sexual dysfunction, a side effect that drives many people to switch or stop their antidepressant. It also doesn’t carry the same risk of weight gain associated with some other antidepressants. On the other hand, the strong sedation and dizziness can be limiting, especially during daytime hours if you’re taking higher doses for depression rather than a low bedtime dose for sleep.
For insomnia specifically, trazodone offers a meaningful trade-off compared to dedicated sleep medications. It’s not quite as effective as drugs like zolpidem at shortening the time to fall asleep, and its sleep benefits may diminish somewhat after the first week. But it avoids the dependency concerns, unusual sleep behaviors, and controlled-substance scheduling that come with those alternatives, which is why many doctors reach for it first when a patient needs long-term help with sleep.